WHO ICTRP trial
A Multi-Centered, Randomized, Blinded, Placebo-Controlled, Serial-Cohort…
NL-OMON35890 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON35890 |
|---|---|
| Public title | A Multi-Centered, Randomized, Blinded, Placebo-Controlled, Serial-Cohort, Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of BG00010 (Neublastin) in Subjects with Sciatica |
| Scientific title | A Multi-Centered, Randomized, Blinded, Placebo-Controlled, Serial-Cohort, Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of BG00010 (Neublastin) in Subjects with Sciatica - Multiple Ascending Dose Study of BG00010 in Subjects With Sciatica |
| Primary sponsor | Biogen Idec Inc. |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Australia;Germany;Netherlands |
| Conditions | low back pain sciatica;10041543;low back pain;sciatica |
| Interventions | 4 ascending IV doses will be examined (50, 150, 400, and 800 µg/kg). Dose escalation will first occur in Part I (the once weekly group). Once escalation is complete up to 800 µg/kg, or a maximum tolerated dose (MTD) is determined, then the… |
| Registration date | Jul 11, 2011 |
| Target size | 56 |
| Secondary IDs | 2011-000681-35;NL36767.056.11 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: